TW202541813A - 水性組成物 - Google Patents

水性組成物

Info

Publication number
TW202541813A
TW202541813A TW114121991A TW114121991A TW202541813A TW 202541813 A TW202541813 A TW 202541813A TW 114121991 A TW114121991 A TW 114121991A TW 114121991 A TW114121991 A TW 114121991A TW 202541813 A TW202541813 A TW 202541813A
Authority
TW
Taiwan
Prior art keywords
aqueous composition
degatinib
salts
aqueous
acid
Prior art date
Application number
TW114121991A
Other languages
English (en)
Chinese (zh)
Inventor
西本明功
喜多亜希子
林紗衣子
Original Assignee
日商樂敦製藥股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商樂敦製藥股份有限公司 filed Critical 日商樂敦製藥股份有限公司
Publication of TW202541813A publication Critical patent/TW202541813A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
TW114121991A 2019-12-27 2020-12-25 水性組成物 TW202541813A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JPJP2019-239599 2019-12-27
JP2019239599 2019-12-27

Publications (1)

Publication Number Publication Date
TW202541813A true TW202541813A (zh) 2025-11-01

Family

ID=76574720

Family Applications (2)

Application Number Title Priority Date Filing Date
TW114121991A TW202541813A (zh) 2019-12-27 2020-12-25 水性組成物
TW109146300A TWI889740B (zh) 2019-12-27 2020-12-25 水性組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
TW109146300A TWI889740B (zh) 2019-12-27 2020-12-25 水性組成物

Country Status (6)

Country Link
US (1) US20230101139A1 (https=)
EP (2) EP4070796B1 (https=)
JP (2) JP7617031B2 (https=)
CN (2) CN119367282A (https=)
TW (2) TW202541813A (https=)
WO (1) WO2021132598A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20220044288A (ko) * 2019-08-07 2022-04-07 로토 세이야쿠 가부시키가이샤 누액 분비 촉진용 안과 조성물
EP4176882A4 (en) * 2020-07-30 2024-01-10 Rohto Pharmaceutical Co., Ltd. AQUEOUS COMPOSITION
TW202448475A (zh) * 2023-03-31 2024-12-16 日商樂敦製藥股份有限公司 眼科組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5575100B2 (ja) * 2004-12-28 2014-08-20 ロート製薬株式会社 プラノプロフェン含有組成物
NZ582188A (en) * 2007-07-11 2012-03-30 Pfizer Pharmaceutical compositions and methods of treating dry eye disorders
TWI466885B (zh) * 2009-07-31 2015-01-01 Japan Tobacco Inc 含氮螺環化合物及其醫藥用途
JP6427497B2 (ja) * 2013-10-21 2018-11-21 日本たばこ産業株式会社 眼疾患の治療剤又は予防剤
CA2991020A1 (en) 2015-07-07 2017-01-12 Japan Tobacco Inc. Method for producing 7h-pyrrolo[2, 3-d]pyrimidine derivative and intermediate thereof
MY196541A (en) * 2015-09-24 2023-04-19 Leo Pharma As Treatment of Alopecia Areata
TWI790218B (zh) 2016-12-21 2023-01-21 日商日本煙草產業股份有限公司 7Ｈ－吡咯并[2,3－ｄ]嘧啶衍生物的製造方法及其共結晶
KR20220044288A (ko) * 2019-08-07 2022-04-07 로토 세이야쿠 가부시키가이샤 누액 분비 촉진용 안과 조성물
JP7722931B2 (ja) * 2019-12-27 2025-08-13 ロート製薬株式会社 水性組成物
US20230285564A1 (en) * 2020-07-30 2023-09-14 Rohto Pharmaceutical Co., Ltd. Aqueous Composition

Also Published As

Publication number Publication date
CN119367282A (zh) 2025-01-28
EP4070796A4 (en) 2024-01-17
EP4674401A2 (en) 2026-01-07
JP7617031B2 (ja) 2025-01-17
EP4070796C0 (en) 2025-12-24
JP2025036714A (ja) 2025-03-14
CN114867480A (zh) 2022-08-05
EP4070796B1 (en) 2025-12-24
JPWO2021132598A1 (https=) 2021-07-01
US20230101139A1 (en) 2023-03-30
TWI889740B (zh) 2025-07-11
EP4674401A3 (en) 2026-02-25
WO2021132598A1 (ja) 2021-07-01
TW202135821A (zh) 2021-10-01
EP4070796A1 (en) 2022-10-12

Similar Documents

Publication Publication Date Title
TWI874894B (zh) 含阿托平之水性組成物
JP2025036714A (ja) 水性組成物
RU2467751C2 (ru) Водные фармацевтические суспензии, содержащие ребамипид, и способ их получения
JP6886878B2 (ja) ドルゾラミドとチモロールと界面活性剤を含有する医薬組成物
JP2025146991A (ja) 水性組成物
TW202045188A (zh) 含有迪夸弗索(diquafosol)或其鹽、乙烯系高分子及纖維素系高分子之眼科用組合物
HK40115610A (zh) 水性组合物
TWI842679B (zh) 含有吡啶基胺乙酸化合物之醫藥
TW200914028A (en) Pirenoxine contented two liquid applying eye drop medicine
JPS639493B2 (https=)
HK40070455A (zh) 水性组合物
TW202135806A (zh) 含西羅莫司(sirolimus)或其鹽之水性懸浮組合物
HK40070460A (en) Aqueous composition
WO2024204749A1 (ja) 眼科組成物
TW202408472A (zh) 眼科組成物
CN115666654A (zh) 药物制剂聚乙二醇基肾上腺髓质素前药和用途
TW202317119A (zh) 用於口服投予之分散錠
TW202519197A (zh) 水性組成物
CN119816297A (zh) 伊马替尼肠胃外给药制剂
WO2014188729A1 (ja) 経口用組成物
EA051764B1 (ru) Офтальмологическая композиция, содержащая левофлоксацин и кеторолак, способ ее получения и ее применение
HK40003059B (zh) 含有阿托品的水性组合物
TW201302755A (zh) 含胺基酸穩定劑的替莫唑胺醫藥組成物及其製備方法